Johnson & Johnson · 2025

Integrating a novel biosensor into
cardiac care

Lactate is one of the most important indicators of cardiac recovery, yet clinicians had no way to monitor it continuously at the bedside. I designed the interface for the first real-time lactate integration on a clinical heart monitor.

Role
UX/UI Co-op
Timeline
July – Dec 2025
Scope
UX/UI/IxD, Prototyping, Data Visualization
AxM prototype walkthrough
01Context

A new sensor, and a new kind of data to design for.

The Impella is the world's smallest heart pump, used when a patient's heart can't sustain blood flow. The Abiomed Auxiliary Monitor (AxM) shows the care team real-time vitals, trends, and alerts from the pump.

Why Lactate Matters

Lactate is a blood metabolite produced when organs aren't receiving enough oxygen. It's one of the clearest indicators of whether a cardiac patient is recovering (currently measured via blood draws every 4–6 hours). A continuous real-time sensor changes that gap significantly.

Abiomed Auxiliary Monitor and AIC on cart
Input 01
Automated Impella Controller (AIC)
Controls the pump. Collects hemodynamic data — flow, P-level, waveform. At max processing capacity.
Existing data source
New Integration
Lactate Biosensor
Continuous real-time blood lactate — first external data source ever integrated onto the AxM. Doesn't yet exist in hospitals.
This project
Data Display
Abiomed Auxiliary Monitor (AxM)
The companion screen runs AI, analytics, and patient management tools the AIC can't host. It surfaces the right data to the right clinician at the right time.

Three Design Constraints

No precedent
The AxM had never displayed external biosensor data. No existing UX patterns to reference.
01
Different data behavior
Lactate is meaningful as a trend over time, requiring different visual treatment from every other metric on screen.
02
Pre-market sensor
The biosensor didn't exist in hospitals yet. I was designing for a technology with no real-world clinical precedent to draw from.
03
02Solution
Original
Original AxM interface
Redesign
Redesigned AxM interface

The Original Interface

The existing AxM pulled from a single data source: the heart pump. The team was also planning to introduce algorithmic decision tools and external biosensors, and the existing interface had no way to support them.

The Solution

I restructured the layout to accommodate new data types and future integrations, introducing a trend system that represents lactate meaningfully while supporting existing clinical workflows.

Feature breakdown

Modular Monitoring Layout

The AxM uses a tile-based design system. Integrating lactate meant introducing a data type that behaves differently from everything else on screen without disrupting the visual hierarchy clinicians rely on during high-pressure moments.

Lactate Tiles

Two tile variations were explored to support different monitoring needs: a simplified view focused on current value and directional change, and an expanded view that also included change from baseline for added clinical context.

Lactate Trend Page

Selecting a lactate tile opens a dedicated trend view where clinicians can inspect values across adjustable time ranges, tap to view exact measurements, and drag across the graph to compare changes over time.

Multi-Trend Comparison

The multi-trend view allows clinicians to compare lactate alongside other hemodynamic metrics, helping identify relationships between signals while maintaining the same interactive inspection behaviours across graphs.

Critical Monitoring Mode

A high-frequency monitoring mode was introduced for severely critical patients, updating lactate values every 20 seconds to 2 minutes. This design decision was informed by contextual inquiry findings showing that rapid spikes could be missed in standard monitoring intervals.

Modular Monitoring Layout Lactate Tiles Lactate Trend Page Multi-Trend Comparison Critical Monitoring Mode
03Outcome
Advanced Development 1

The project advanced to its next development stage.

Advanced Development 1 (AD1) is J&J's internal gate for demonstrating clinical and technical feasibility before committing further R&D resources. The prototypes passed, showing that this integration was something physicians would actually use, for a sensor that doesn't yet exist in hospitals.

04 Process

How did I get here?

There were no existing UX patterns for continuous lactate on a clinical monitor, so I started by just trying to understand the space: who actually uses this data, when it matters, and what they do with it when it does.

01
Secondary Research · Expert Interviews

Getting up to speed on the clinical side

Before sketching anything, I spent time on literature reviews and internal artifacts to get a handle on biomarkers, hemodynamics, and how lactate fits into the Impella workflow. I also spoke with two principal scientists from the academic research team and the Director of the Critical Care Platform, people who knew the clinical workflows deeply. Together this gave me enough context to ask the right questions before talking to clinicians directly.

Clinical Context Clinical Workflow User Needs
02
User Journey Mapping

Where does lactate actually come up?

Lactate means different things at different points in the patient journey. I mapped out both workflows to get a clearer picture of when it's being watched, by whom, and what they're deciding based on it.

Initial Assessment
Lactate is combined with vitals to triage severity and guide first decisions
Active Treatment
Tells clinicians if the pump support is working. Rapid changes signal complications
Recovery Monitoring
The primary stage for this design as trends over time influence treatment decisions
Treatment & Implantation journey User journey map: Treatment & Implantation
Monitoring journey User journey map: Monitoring
03
Ideation · Design Workshop

Running a workshop with the broader team

We brought together the algorithms and engineering teams to generate concepts around tile structure, action triggers, and trend interpretation. After dot-voting, we landed on a lactate-focused flow that 5/5 clinical consultants preferred in early feedback — mainly because it was simple and didn't require much cognitive overhead to act on.

Design workshop in session
Team at whiteboard presenting concepts
Affixing sketches to the board
Design workshop output: affinity diagram of concepts
04
Ideation · Wireframes

Sketching out what the interface could look like

With a baseline understanding of the clinical context, I started generating early wireframe concepts exploring different ways to display continuous lactate data on the existing AxM screen. This included tile layout variations and different approaches to showing trend over time.

Tile Layout Variations Wireframes - tile layout variations
✦ Metric focused layout — chosen Wireframes - Metric Focused Layout
Trend Overview Layout Wireframes - Trend Overview Layout
05
Clinical Feedback · 5 Clinical Consultants · 30 min each

Testing early concepts with clinicians

I ran semi-structured interviews with 5 clinical consultants to check whether the early wireframe concepts matched how clinicians actually think about lactate during patient monitoring. The goal was to figure out which interaction model better supports real decision-making moments — and where the concepts were off.

Primary user —
Critical Care Physician
Intensivist / Critical Care Physician persona
Primary user —
Critical Care Nurse
Critical Care Nurse persona
Secondary user —
Interventional Cardiologist
Interventional Cardiologist persona
Design Decision — Wireframe Direction

Clinicians prefered the metric-focused layout as the interaction of tapping a tile to drill into a dedicated trend page felt more intuitive and kept clinicians focused on one metric at a time.

Metric tile → trend page interaction Design decision: metric focused layout selected
Design Decision — Tile Update

Clinicians responded well to the large number display and directional arrow, but wanted change from baseline rather than percentage change.

Original: % change Original tile
✦ Updated: change from baseline Updated tile
06
Contextual Inquiry · Animal Study

Watching the prototype in a real clinical scenario

I had the opportunity to participate in a lactate-focused animal study with clinicians and stakeholders. During the session, we found that the data update frequency we'd been using, based on earlier clinical consultant feedback, caused people to miss significant spikes in lactate, particularly in more critical cases. Because of this, I added a high-frequency monitoring mode specifically for critical conditions. It was a straightforward fix, but one that wouldn't have come up in a regular prototype review since it only became visible with fast-moving live data.

Design Decision — Critical Monitoring Mode

I introduced a high-frequency mode with more granular timeframes and rapid real-time updates (every 20 seconds to 2 minutes) for patients in critical condition. Standard intervals weren't fast enough to catch sudden lactate spikes.

Critical monitoring mode: rapid real-time updates
Critical monitoring mode with rapid updates

This page is password protected.

Incorrect password